$AMGN AMGEN INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in AMGEN INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in AMGEN INC. Insider overview, share value development, latest insider transactions and email notifications about new events in AMGEN INC for free.

CIK Number: 0000318154
IRS Number: 953540776
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: AMGN
Company Address: ONE AMGEN CENTER DRIVE THOUSAND OAKS 91320
Phone number: (805) 447-1000
Former name: AMGEN, date of change: 1987-03-05

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Market Capitalization: $124.07B
Prev close: $166.82
Average Daily Volume: 3,895,330
Days Low: $166.32
Year Low: $133.64
Year High: $176.85

AMGEN INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Austin Wanda MDirector1,221203,687shares bought: 1,221 / shares sold: 0 STRONG BUYMay 01 20183 months ago
BALTIMORE DAVIDDirector32,2865,385,951shares bought: 8,636 / shares sold: -8,700 SELLMay 01 20183 months ago
Bradway Robert AChairman, CEO and President431,10171,916,269shares bought: 94,321 / shares sold: -139,857 SELLMay 07 20182 months ago
de Carbonnel FrancoisDirector16,6862,783,559shares bought: 8,636 / shares sold: -7,514 BUYMay 01 20183 months ago
ECKERT ROBERTDirector9,4881,582,788shares bought: 3,636 / shares sold: 0 STRONG BUYMay 01 20183 months ago
Garland Greg C.Director7,0511,176,248shares bought: 3,636 / shares sold: 0 STRONG BUYMay 01 20183 months ago
Graham Jonathan PSVP, Gen. Counsel & Secy.47,3667,901,596shares bought: 9,172 / shares sold: -13,707 SELLMay 07 20182 months ago
Harper Sean EEVP, Research & Development57,5109,593,818shares bought: 51,746 / shares sold: -84,753 SELLJun 12 20181 month ago
HASSAN FREDDirector7,2181,204,107shares bought: 3,636 / shares sold: 0 STRONG BUYMay 01 20183 months ago
HENDERSON REBECCA MDirector13,1112,187,177shares bought: 3,636 / shares sold: 0 STRONG BUYMay 01 20183 months ago
HERRINGER FRANK CDirector50,8758,486,968shares bought: 8,636 / shares sold: -1,745 STRONG BUYMay 01 20183 months ago
HOLLEY CHARLES MDirector2,488415,048shares bought: 2,458 / shares sold: 0 STRONG BUYMay 01 20183 months ago
HOOPER ANTHONY CEVP, Global Commercial Ops.215,14735,890,823shares bought: 55,274 / shares sold: -50,807 BUYMay 07 20182 months ago
Jacks TylerDirector8,8811,481,528shares bought: 3,636 / shares sold: 0 STRONG BUYMay 01 20183 months ago
Johnston Lori ASVP, HR17,0852,850,120shares bought: 8,791 / shares sold: -441 STRONG BUYMay 01 20183 months ago
Kullman Ellen JamisonDirector2,974496,123shares bought: 2,886 / shares sold: 0 STRONG BUYMay 01 20183 months ago
Meline David WEVP & CFO59,3829,906,105shares bought: 28,408 / shares sold: -23,675 BUYMay 07 20182 months ago
Onyx Therapeutics, Inc.10% Owner1,121,384187,069,279shares bought: 1,121,384 / shares sold: 0 BUYJun 25 201822 days ago
Patton Cynthia MSVP & CCO24,1564,029,704shares bought: 11,438 / shares sold: -14,983 SELLMay 07 20182 months ago
Piacquad DavidSVP, Business Development51,5668,602,240shares bought: 27,630 / shares sold: -20,573 BUYMay 15 20182 months ago
Santos EstebanEVP, Operations36,4666,083,258shares bought: 15,129 / shares sold: -5,521 STRONG BUYMay 07 20182 months ago
SUGAR RONALD DDirector12,7212,122,117shares bought: 3,636 / shares sold: 0 STRONG BUYMay 01 20183 months ago
Williams R SandersDirector5,136856,788shares bought: 3,636 / shares sold: 0 STRONG BUYMay 01 20183 months ago

View all AMGEN INC insiders.

AMGEN INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 25 2018AMGNAMGEN INCOnyx Therapeutics, Inc.10% OwnerOption ExerciseC0.001,121,38400
Jun 25 2018AMGNAMGEN INCOnyx Therapeutics, Inc.10% OwnerBuyC0.001,121,38401,121,3840 to 1.1 M
Jun 12 2018AMGNAMGEN INCHarper Sean EEVP, Research & Dev ...SellS184.271,525281,01257,51059 K to 57.5 K (-2.58 %)
May 15 2018AMGNAMGEN INCPiacquad DavidSVP, Business Devel ...Option ExerciseM54.7115,000820,6500
May 15 2018AMGNAMGEN INCPiacquad DavidSVP, Business Devel ...Payment of ExerciseF170.779,8601,683,79241,70651.6 K to 41.7 K (-19.12 %)
May 15 2018AMGNAMGEN INCPiacquad DavidSVP, Business Devel ...BuyM54.7115,000820,65051,56636.6 K to 51.6 K (+41.02 %)
May 15 2018AMGNAMGEN INCHarper Sean EEVP, Research & Dev ...SellS174.101,525265,50359,03560.6 K to 59 K (-2.52 %)
May 07 2018AMGNAMGEN INCSantos EstebanEVP, OperationsPayment of ExerciseF169.4317830,15936,46636.6 K to 36.5 K (-0.49 %)
May 07 2018AMGNAMGEN INCPiacquad DavidSVP, Business Devel ...Payment of ExerciseF169.4317830,15936,56636.7 K to 36.6 K (-0.48 %)
May 07 2018AMGNAMGEN INCPatton Cynthia MSVP & CCOPayment of ExerciseF169.4316928,63424,15624.3 K to 24.2 K (-0.69 %)
May 07 2018AMGNAMGEN INCMeline David WEVP & CFOPayment of ExerciseF169.43773130,96959,38260.2 K to 59.4 K (-1.29 %)
May 07 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF169.43883149,607215,147216 K to 215.1 K (-0.41 %)
May 07 2018AMGNAMGEN INCHarper Sean EEVP, Research & Dev ...Payment of ExerciseF169.43736124,70060,56061.3 K to 60.6 K (-1.20 %)
May 07 2018AMGNAMGEN INCGraham Jonathan PSVP, Gen. Counsel & ...Payment of ExerciseF169.4339066,07847,36647.8 K to 47.4 K (-0.82 %)
May 07 2018AMGNAMGEN INCBradway Robert AChairman, CEO and P ...Payment of ExerciseF169.432,312391,722431,101433.4 K to 431.1 K (-0.53 %)

View all AMGEN INC insider transactions.